If you’ve felt unusually drowsy, dizzy, or mentally foggy after taking progesterone, the neurosteroid allopregnanolone may be the reason. This powerful metabolite of progesterone influences brain function, mood, and stress response, but its calming effects can sometimes feel overwhelming. In this article, we explore what allopregnanolone is, why it causes side effects like dizziness, what factors influence its activity, and how to support your body’s ability to metabolize it effectively.
Allopregnanolone is a fascinating molecule with significant implications for mental and neurological health. For the layperson, it’s a substance your body makes from progesterone that can affect how you feel, from calm and relaxed to overly sedated. For professionals, its role as a neurosteroid and GABA receptor modulator makes it a key player in conditions like postpartum depression and premenstrual syndrome (PMS). Understanding its effects can help you manage progesterone-related symptoms more effectively.
Recent studies highlight that allopregnanolone levels fluctuate dramatically in response to hormonal changes, such as during the menstrual cycle or pregnancy, potentially exacerbating mood disorders in susceptible individuals. This variability underscores the need for personalized approaches to hormone therapy, as what works for one person might trigger adverse reactions in another.
To put this into perspective, consider that millions of women worldwide use progesterone supplements for various reasons, including hormone replacement therapy, fertility treatments, or managing menstrual irregularities. Yet, up to 20-30% report side effects like fatigue or dizziness, often without realizing the underlying neurosteroid connection.
What Is Allopregnanolone?
Allopregnanolone is a neuroactive steroid, meaning it directly influences brain signaling. It’s primarily derived from progesterone, a hormone critical for reproduction, mood regulation, and stress response. The body converts progesterone into allopregnanolone through a two-step enzymatic process: first, the enzyme 5α-reductase transforms progesterone into an intermediate called 5α-dihydroprogesterone; then, 3α-hydroxysteroid dehydrogenase converts this intermediate into allopregnanolone.
This synthesis occurs in multiple tissues, including the liver, adrenal glands, and notably the brain (e.g., cortex, hippocampus, and amygdala). Allopregnanolone can also be produced directly in the brain from cholesterol, which is converted to pregnenolone, then progesterone, and finally allopregnanolone. This brain-specific production classifies it as a true neurosteroid, allowing it to act locally on neural circuits.
It’s worth noting that allopregnanolone’s synthesis is tightly regulated by enzymatic activity and precursor availability. Variations in these pathways can influence its effects, which we’ll explore later. Think of allopregnanolone as a natural “calming agent” produced from hormones, but one that can sometimes overdo its job, leading to side effects.
Historically, allopregnanolone was first identified in the 1930s as a progesterone metabolite, but its neuroactive properties weren’t fully appreciated until the 1980s when researchers linked it to GABA receptor modulation. Today, it’s at the forefront of neuropsychiatric research, with implications for anxiety, depression, and even epilepsy. Its lipophilic nature allows it to cross the blood-brain barrier easily, amplifying its central nervous system effects.
Functions of Allopregnanolone
Allopregnanolone plays diverse roles in the body, impacting mental and neurological health. Below are its key functions, each with implications for both everyday well-being and clinical practice.
GABA Receptor Modulation
Allopregnanolone enhances the activity of GABA receptors, the brain’s primary inhibitory system. This produces calming, anti-anxiety, and sedative effects, similar to medications like benzodiazepines. For the average person, this means allopregnanolone can help you feel relaxed, but too much can make you feel overly sleepy or foggy.
Allopregnanolone’s action as a modulator of GABA-A receptors explains its potent anxiolytic and sedative properties. This makes it a target for therapeutic interventions, as seen in treatments for mood disorders. Studies in animal models show that allopregnanolone increases the frequency and duration of GABA-A channel opening, leading to hyperpolarization of neurons and reduced excitability.
Mood and Stress Regulation
Allopregnanolone has antidepressant and anxiolytic properties, helping to reduce stress and improve mood. Fluctuations in its levels are linked to conditions like premenstrual syndrome (PMS) and mood disorders. For example, low levels during certain menstrual cycle phases may contribute to anxiety or irritability.
These fluctuations are significant in disorders like premenstrual dysphoric disorder (PMDD) or postpartum depression, where allopregnanolone dysregulation is implicated. Patients may notice mood swings or stress sensitivity tied to hormonal changes. Research indicates that allopregnanolone modulates the hypothalamic-pituitary-adrenal (HPA) axis, dampening cortisol release during stress.
Neuroprotection and Cognitive Effects
Allopregnanolone supports brain health by promoting neural repair and protection. It also influences memory, cognition, and acts as a natural painkiller and anticonvulsant. This means it helps keep your brain healthy and can reduce pain or seizure risk.
In clinical settings, its neuroprotective properties are being studied for conditions like traumatic brain injury and neurodegenerative diseases. However, excessive levels may impair cognition, leading to symptoms like brain fog, which is relevant for patients on progesterone therapy. Preclinical data suggest allopregnanolone promotes myelin repair and reduces inflammation, offering potential in multiple sclerosis or Alzheimer’s.
Why Does Progesterone Cause Drowsiness and Dizziness?

If you’ve taken progesterone supplements and felt sleepy, dizzy, or mentally foggy, allopregnanolone is likely the culprit. When you take progesterone (orally, topically, or otherwise), your body metabolizes some of it into allopregnanolone via the enzymes 5α-reductase and 3α-hydroxysteroid dehydrogenase.
Allopregnanolone’s action on GABA receptors creates a calming, sedative effect, which can manifest as drowsiness, fatigue, or impaired cognition. Dizziness may occur due to slowed central nervous system activity, particularly in individuals sensitive to these effects. This might feel like needing a nap after taking progesterone.
Clinical studies show that individuals with higher blood levels of allopregnanolone (and its related compound, pregnanolone) experience more pronounced fatigue and delayed recall compared to those with lower levels. This suggests that monitoring allopregnanolone metabolites may help predict side effects in patients on progesterone therapy. Individual differences in metabolism also play a role in these effects. For instance, a study involving women on oral progesterone found that peak allopregnanolone levels correlated with self-reported sedation scores, emphasizing the dose-dependent nature of these symptoms. Additionally, vestibular disturbances leading to dizziness might stem from allopregnanolone’s influence on cerebellar GABA receptors, which coordinate balance and motor function.
The conversion process involves specific enzymes that can vary in activity among individuals, leading to different levels of allopregnanolone from progesterone.
Allopregnanolone in Postpartum Depression Treatment
Allopregnanolone’s role in mood regulation has led to a groundbreaking treatment. In 2019, the FDA approved brexanolone (sold as Zulresso®), a synthetic form of allopregnanolone, as the first drug specifically for postpartum depression. Administered intravenously over 60 hours in a clinical setting, brexanolone modulates GABA receptors to produce rapid antidepressant effects, often within days—faster than traditional antidepressants.
Why Do Some Experience Stronger Allopregnanolone Effects?
Not everyone reacts to progesterone or allopregnanolone the same way. Several factors influence how much allopregnanolone is produced and how strongly it affects you.
Enzymatic and Hormonal Factors
Differences in the activity of 5α-reductase and 3α-hydroxysteroid dehydrogenase determine how much allopregnanolone is produced from progesterone. Higher progesterone levels, such as during the luteal phase or pregnancy, result in more allopregnanolone. Women typically have higher levels than men, and levels fluctuate with age.
Enzymatic efficiency is a key consideration when using progesterone. Those with more active enzymes may experience stronger side effects. Hormonal fluctuations, such as those in PMDD or pregnancy, can amplify allopregnanolone’s effects.
Genetic and Environmental Influences
Genetic polymorphisms in enzymes or GABA receptor subunits can affect allopregnanolone production and receptor sensitivity. Chronic stress, anxiety, or mood disorders can also alter allopregnanolone levels by affecting enzyme activity or receptor regulation. Lifestyle factors like diet, sleep, and exercise indirectly influence hormonal balance.
This means your genetics, stress levels, and lifestyle can make you more or less sensitive to progesterone’s effects. These factors highlight the need for personalized approaches to hormone therapy, considering both genetic and environmental influences. Epigenetic modifications from early life stress may downregulate GABA-A receptors, exacerbating allopregnanolone’s impact. Obesity and smoking further modulate levels, with studies showing reduced allopregnanolone in smokers, potentially worsening stress responses.
Does Progesterone Directly Affect GABA Receptors?
Progesterone does not directly bind to GABA receptors. Its effects on the GABA system are primarily indirect through its conversion to allopregnanolone. Progesterone mainly acts via classical progesterone receptors for slower, genomic effects (e.g., regulating gene expression). When metabolized into allopregnanolone, it exerts rapid, non-genomic effects by enhancing GABA receptor activity.
This explains why progesterone supplements can cause sedation or dizziness—effects driven by allopregnanolone, not progesterone itself. Understanding this distinction is crucial when managing side effects or considering therapies targeting GABA receptors.
Some non-genomic effects of progesterone may involve other signaling pathways, but these are less significant for GABA modulation. This indirect mechanism underscores the importance of allopregnanolone in progesterone’s neurological effects. In vitro studies confirm progesterone’s lack of direct affinity for GABA-A sites, reinforcing the metabolite’s primacy.
Where Is Allopregnanolone Produced?
Allopregnanolone is synthesized in several parts of the body, reflecting its role as both a systemic and local neurosteroid. In the brain, regions like the cortex, hippocampus, and amygdala produce allopregnanolone from cholesterol or progesterone, making it a true neurosteroid with localized effects.
The liver metabolizes circulating progesterone into allopregnanolone, contributing to systemic levels. The adrenal glands produce precursor hormones like pregnenolone, which can lead to allopregnanolone synthesis, while the ovaries in women generate progesterone, a key precursor.
The brain’s ability to synthesize allopregnanolone independently of peripheral hormones is significant for understanding its role in neurological conditions. Knowing that allopregnanolone is made in both the brain and body helps explain its widespread effects on mood and cognition.
Other Drugs That Affect GABA Receptors
Allopregnanolone isn’t the only substance that modulates GABA receptors. Several drugs and compounds target this system, producing similar calming or sedative effects.
Benzodiazepines and Related Drugs
Benzodiazepines (e.g., diazepam, alprazolam) enhance GABA receptor activity, increasing chloride channel opening for anxiolytic and sedative effects. Non-benzodiazepine hypnotics like zolpidem bind to similar sites but have distinct structures, often used for sleep.
Other GABA Modulators
Barbiturates (e.g., phenobarbital) modulate GABA receptors and can act as direct agonists at high doses. Alcohol (ethanol) indirectly enhances GABA activity, contributing to its relaxing effects. General anesthetics like propofol and GABA agonists like baclofen or GHB also target GABA receptors for sedation or muscle relaxation.
Supporting Allopregnanolone Metabolism
If you’re experiencing excessive sedation or dizziness from allopregnanolone (e.g., after progesterone supplementation), supporting your body’s detoxification pathways can help. The liver metabolizes allopregnanolone via glucuronidation and sulfation, preparing it for excretion. Below are strategies to support these pathways.
Glucuronidation Support
Calcium D-glucarate inhibits beta-glucuronidase, ensuring efficient hormone clearance. Found in supplements or foods like oranges, it supports glucuronidation. Quercetin, a plant antioxidant in onions and apples, and curcumin from turmeric upregulate glucuronidation enzymes.
Cruciferous vegetables like broccoli and kale contain sulforaphane, boosting phase II detox enzymes. Vitamin B3 (niacin) provides NADPH, a cofactor for glucuronidation, supporting efficient metabolism.
Sulfation and General Detox Support
N-acetylcysteine (NAC) supplies sulfur for sulfation and boosts glutathione, another detox pathway. Magnesium supports both glucuronidation and sulfation, while B vitamins (B6, folate, B12) aid sulfation and methylation.
Lifestyle factors like hydration (8–10 cups of water daily), quality sleep, regular exercise, and a diet low in processed foods support liver and kidney function. Fiber-rich diets promote bile excretion of conjugated metabolites, reducing recirculation. Herbal supports like milk thistle (silymarin) enhance overall liver regeneration, indirectly aiding neurosteroid clearance.
Final Thoughts
Allopregnanolone is a powerful neurosteroid that explains many of progesterone’s effects, from calming mood to causing drowsiness or dizziness. Supporting your body’s detoxification pathways with natural substances and lifestyle changes can help balance allopregnanolone’s effects.